News

DeFi Technologies Faces Class Action Amid Revenue Concerns

DeFi Technologies Faces Class Action Amid Revenue Concerns

DeFi Technologies Faces Class Action Amid Revenue Concerns

DeFi Technologies Inc. is currently navigating tumultuous waters as it faces a class action lawsuit concerning significant revenue losses. Investors are urged to be vigilant and contact legal representatives before the critical deadline arrives. The Company, identified by its stock ticker NasdaqCM: DEFT, is under scrutiny due to allegations of securities fraud that may have affected numerous stakeholders.

Understanding the Class Action Lawsuit

This lawsuit is being pursued by Kahn Swick & Foti, a renowned law firm specializing in securities litigation, led by the distinguished Charles C. Foti, Jr. Investors who held shares in DeFi Technologies between May 12, 2025, and November 14, 2025, might be entitled to recover losses sustained during this period. This notable legal action is not just about financial losses; it represents a collective effort to ensure accountability and transparency within the company.

The Allegations and Financial Fallout

At the core of this legal challenge lies an alarming announcement made by DeFi Technologies on November 13, 2025. The Company revealed dismal financial results for the third quarter, reporting an astounding near 20% decline in revenue compared to market expectations. Adding to the distress, the Company drastically slashed its revenue forecast for 2025 from $218.6 million to about $116.6 million due to setbacks in executing anticipated arbitrage opportunities. Following this news, the share price plummeted, demonstrating the concerns of investors.

In the wake of this significant decline, shares fell by $0.40 or 27.59%, closing at just $1.05 on November 17, 2025. This drastic change appears to have heightened scrutiny and led to the filing of the class action lawsuit against DeFi Technologies, emphasizing the need for the Company to clarify the circumstances surrounding these financial figures.

Steps for Investors to Take

Investors inspired to join the lawsuit must act quickly. The deadline to apply as lead plaintiff is set for January 30, 2026. However, potential plaintiffs should be aware that participating as a lead plaintiff is not a requirement to benefit from any eventual recovery. It is crucial for investors to connect with the legal team of Kahn Swick & Foti promptly to understand their rights and potential avenues for recourse.

About Kahn Swick & Foti, LLC

With a solid reputation in the realm of securities litigation, Kahn Swick & Foti, LLC boasts a dedicated team led by former Louisiana Attorney General Charles C. Foti, Jr. The firm has consistently been recognized among the top-tier litigation firms in the United States based on settlement values achieved. They have effectively represented a wide array of clients—from institutional investors to retail traders—in recovering investments lost due to corporate malfeasance.

The firm’s expansive network includes offices in various key locations, which enables them to serve a diverse client base effectively. Investors looking for guidance can reach out to KSF Managing Partner Lewis Kahn for support, ensuring they receive the assistance needed in navigating this intricate legal process.

Connecting with Legal Support

If you are a shareholder of DeFi Technologies and have faced losses during the specified timeframe, now is the time to seek expert advice. The legal assistance provided by Kahn Swick & Foti can be instrumental in addressing your concerns and navigating the complexities of the class action lawsuit.

Frequently Asked Questions

What is the Class Action Lawsuit Against DeFi Technologies?

This lawsuit aims to address claims of securities fraud that affected investors during a specified timeframe due to significant revenue losses.

Who Can Participate in the Lawsuit?

Investors who held shares from May 12, 2025, to November 14, 2025, and faced financial losses can participate in seeking recovery.

When is the Deadline to Apply as Lead Plaintiff?

The deadline to request appointment as lead plaintiff is January 30, 2026.

How Can Investors Contact Support?

Investors can contact Kahn Swick & Foti, LLC, for personalized assistance regarding the lawsuit and their rights.

What Should Investors Do Next?

Affected investors should reach out as soon as possible to understand their options and secure legal representation before the deadline.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 247

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Atakama and PKWARE Join Forces for Enhanced Data Security Solutions

Updated Category News Views 165

Atakama Partners with PKWARE for Enhanced Data Security PKWARE, a leader in automated data security solutions, has announced a strategic partnership with Atakama, known for its multifactor encryption technology. This collaboration aims to provide a seamless transition for Atakama customers as the Atakama Multifactor Encryption (MFE) solution approaches its end-of-life in...

Continue Reading
Chapters Health System Revamps National Grief Support Initiatives

Updated Category News Views 74

Transforming Grief Support for Children Chapters Health System has taken significant steps in rebranding its grief support camps for children under a unified name and logo: Camp Brave Heart. This initiative is set to launch in 2026, reflecting the organization's dedication to providing a nurturing and supportive environment for children experiencing the loss of a loved...

Continue Reading
Carter's Earnings Forecast: Analysts Weigh In on Performance

Updated Category News Views 222

Carter's Prepares for Earnings Report Carter’s, Inc. (NYSE: CRI) is set to announce its earnings results for the upcoming third quarter soon. Analysts are closely watching as this release approaches. Expectations are building around their performance and the company's strategies to navigate a challenging market environment. Analysts' Forecasts and Expectations The...

Continue Reading
Explore Bradford White's Innovative Water Heating Solutions

Updated Category News Views 134

Bradford White Showcases Water Heating Innovations Bradford White Corporation, renowned for its high-quality water heating solutions, is preparing to be a Diamond Sponsor at a significant upcoming industry event. This conference is a vital platform for engaging in discussions about plumbing, heating, and cooling practices that are becoming increasingly important in...

Continue Reading
Intel Plans to Seek Investment for Altera Division

Updated Category News Views 103

Intel got its eyes set on its Altera chipmaking division back in the day, looking to scoop up some serious cash from minority stake investments. They projected a whopping $17 billion valuation for this slice, which could be a game changer for Intel trying to shore up its financial standing. But let’s not kid ourselves; they’re still feeling the sting from previous...

Continue Reading